AstraZeneca COVID-19 vaccine trial Brazil volunteer dies

Tell a friend about this post

Oxford confirmed the plan to keep testing, saying in a statement that after careful assessment “there have been no concerns about safety of the clinical trial.”

AstraZeneca declined to comment immediately.

A source familiar with the matter told Reuters the trial would have been suspended if the volunteer who died had received the COVID-19 vaccine, suggesting the person was part of the control group that was given a meningitis jab.

The Federal University of Sao Paulo, which is helping coordinate phase 3 clinical trials in Brazil, said an independent review committee had also recommended the trial continue. The university earlier confirmed the volunteer was Brazilian but gave no further personal details.

 

More

Tell a friend about this post
READ ALSO  COVID-19 accelerates greater trade coordination in East Africa – News

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

You cannot copy content of this page